ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Validfor Launches Agentic Digital Validation Platform Delivering Four-Week Go-Lives for Pharma

Validfor is excited to announce the launch of its Agentic Digital Validation Platform for life sciences, designed to modernize validation lifecycle management with data-driven workflows, real-time traceability, and rapid deployments that have reached production in as little as four weeks for paying customers.

-- Validfor, an EU-based B2B SaaS company focused on life sciences compliance, is excited to announce the launch of its Agentic Digital Validation Platform, built to modernize validation lifecycle management (VLM) and computerized system validation (CSV), while also supporting a broad range of GxP validation disciplines including commissioning and qualification (CQV), process validation, cleaning validation, equipment and facility qualification, and other regulated validation activities across pharmaceutical, biotech, and medical device organizations.

Pharmaceutical organizations are accelerating digital transformation while managing increasing system complexity, more frequent change cycles, and higher expectations for traceability and data integrity. Traditional CSV validation approaches built around spreadsheets, static documents, and manual approvals can slow execution, introduce inconsistency, and reduce visibility into operational risk. Validfor is designed to help regulated teams shift from document-centered validation to continuous lifecycle control.

The Validfor platform manages structured workflows across requirements, risk, design, test execution, deviations, change control, and periodic review. Instead of relying on retrospective reporting, Validfor connects validation objects in a single system of record to support real-time traceability across the validation lifecycle. The platform is designed to support compliance requirements commonly applied in life sciences, including FDA 21 CFR Part 11 and EU Annex 11 expectations, alongside GAMP5, ALCOA+, and CSA-aligned practices.

“True digital validation goes beyond uploading PDFs. It delivers automation, end-to-end traceability, and real-time audit readiness,” said Ugur Metinol, Co-Founder and COO of Validfor.

Validfor is built for cross-functional stakeholders responsible for validated systems, including Quality, Compliance, CSV, IT, and digital transformation teams. The platform supports configurable workflows without coding, helping organizations standardize processes across sites and regions while maintaining governance consistency.

“Validation should operate as a living control system, not a document backlog,” said Omer Cimen, CEO and Co-Founder of Validfor. “Validfor is focused on helping teams strengthen control while reducing manual effort across the validation lifecycle.”

According to company-reported results, paying customers have achieved production go-live in as little as four weeks. Validfor also reports measurable outcomes that include a 70 to 90 percent reduction in manual labor and a 75 percent acceleration in validation and review cycles, supported by operational reliability metrics including 99.5 percent or higher uptime and zero churn to date.

Founded in 2025 and headquartered in Tallinn, Estonia, Validfor operates with a distributed international structure designed for regulated, cross-border deployments. The founding team brings nearly 30 years of combined experience in pharma compliance across more than 20 countries.

For more information about Validfor and the Agentic Digital Validation Platform, please visit: https://validfor.com

About Validfor
Validfor is a US/EU-based B2B SaaS company building an Agentic Digital Validation Platform for life sciences. The platform enables data-driven validation workflows, real-time traceability across the validation lifecycle, and continuous oversight to help pharmaceutical, biotech, and medical device organizations modernize validation operations in regulated environments.

Contact Info:
Name: Omer Cimen
Email: Send Email
Organization: Validfor
Phone: +90 850 885 0276
Website: https://validfor.com

Release ID: 89182040

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.35
-18.34 (-8.24%)
AAPL  279.09
+3.18 (1.15%)
AMD  207.94
+15.44 (8.02%)
BAC  56.26
+1.32 (2.39%)
GOOG  322.40
-8.93 (-2.70%)
META  657.00
-13.21 (-1.97%)
MSFT  395.95
+2.28 (0.58%)
NVDA  183.88
+12.00 (6.98%)
ORCL  141.39
+4.91 (3.60%)
TSLA  410.03
+12.82 (3.23%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.